2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
AssigneeReata Pharmaceuticals, Inc.
InventorsEric Anderson, Xiaofeng Liu, Andrea Decker
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to the compound: N-((4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,2,3,4,4a,5,6,6a,6b,7, 8,8a,9,10,12a,14,14a,14b-octadecahydropicen-4a-yl)-2,2-difluoropropanamide, polymorphic forms thereof, methods for preparation and use thereof, pharmaceutical compositions thereof, and kits and articles of manufacture thereof.
Claims2
A method for ameliorating or effecting any measurable decrease in a seizure disorder in a patient in need thereof, comprising administering to the patient an effective amount of a compound of the formula:
- wherein the seizure disorder is epilepsy.
A method of ameliorating or effecting any measurable decrease in a neurodegenerative disease in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a compound of the formula:
- wherein the neurodegenerative disease is Parkinson's disease, Alzheimer's disease, multiple sclerosis, Huntington's disease, or amyotrophic lateral sclerosis.
Dependencies are inferred from the claim text.